A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis

• Status: Completed
• Trial end date: 2011-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety and efficacy of K-604 for the treatment of atherosclerosis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kowa Research Institute, Inc.

Criteria

Inclusion Criteria:

• moderate carotid artery stenosis

Exclusion Criteria:

• history of arteritis

• heavily calcified plaque

• uncontrolled hypertension

• poorly controlled diabetes

• hypercholesterolemia